Conceptio
›
non-small-cell-lung-cancer
Topic
non-small-cell-lung-cancer
Knowledge-graph topic
· documents ABOUT non-small-cell-lung-cancer across the archive
1,034
Documents about non-small-cell-lung-cancer
Documents about non-small-cell-lung-cancer
Concurrent Radiotherapy With Weekly Topotecan for Primary Treatment of Inoperable Localized Non-small Cell Lung Cancer
#841502
ClinicalTrials.gov
Liquid BiOpsy, Lung and Colon Cancer in AndaluciA
#195316
ClinicalTrials.gov
Evaluation of Efficacy and Toxicity of Nivolumab Monotherapy for Advanced Non-small Cell Lung Cancer After First-line Treatment Failure Based on Second-generation Sequencing and Liquid Chip Platform
#287533
ClinicalTrials.gov
Circulating Fatty Acid Profile as a Biomarker for Immunotherapy in Advanced Non-Small Cell Lung Cancer
#340174
IRIS
A Study to Compare Uliledlimab Combined With Sintilimab and Chemotherapy Versus Sintilimab Combined With Chemotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer
#810692
ClinicalTrials.gov
A Randomized, Open-label, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Treatment of Physician's Choice in Subjects With Advanced Non-Small Cell Lung Cancer
#839791
ClinicalTrials.gov
Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
#321708
ClinicalTrials.gov
Adjuvant Targeted-therapy for Patients With Resected High-risk EGFR-mutant Stage IB-IIA Non-small Cell Lung Carcinoma
#826826
ClinicalTrials.gov
POTENT - Tepotinib in Combination With Pembrolizumab in NSCLC
#143574
ClinicalTrials.gov
Sotorasib in Advanced KRASG12C-mutated Non-small Cell Lung Cancer Patients With Comorbidities
#226244
ClinicalTrials.gov
A Study of SKB264 in Combination With Osimertinib Versus Osimertinib in Patients With Epidermal Growth Factor Receptor (EGFR) Mutations, Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
#825253
ClinicalTrials.gov
Novel Epigenetic Mapping in Cell-Free DNA for the Detection of Lung Cancer
#812838
ClinicalTrials.gov
Midterm survival of imaging-assisted robotic lung segmentectomy for non-small-cell lung cancer
#26242
HAL (France)
Regulation of the ERK-MAPK signaling by the small GTPase RHOB in a cell model of non-small cell lung cancer
#238940
HAL (France)
Pembrolizumab + Platinum Doublets Without Radiation for Programmed Death-ligand 1 (PD-L1) ≥50% Locally Advanced NSCLC
#813003
ClinicalTrials.gov
Immunopeptidomics-guided identification of functional neoantigens in non-small cell lung cancer
#10111
bioRxiv / medRxiv
ctDNA as a Biomarker for Treatment in Advanced NSCLC
#148734
ClinicalTrials.gov
Sintilimab Versus Pembrolizumab for Advanced-stage Non-Small-Cell Lung Cancer
#160355
ClinicalTrials.gov
Daratumumab in STK11 Mutated NSCLC
#245496
ClinicalTrials.gov
Adjuvant Durvalumab in Completely Resected Early-Stage Non–Small Cell Lung Cancer
#311904
HAL (France)
Phase II Trial of Continuation Therapy in Advanced NSCLC
#683088
ClinicalTrials.gov
Prediction of Immunotherapeutic Effect of Advanced Non-small Cell Lung Cancer
#837146
ClinicalTrials.gov
A Phase 2 Randomized, Controlled Trial of QL1706 Plus Chemotherapy and Quad Shot for Driver Gene-negative Advanced Non-small Cell Lung Cancer.
#201789
ClinicalTrials.gov
CHEMICAL DESIGN OF NIR-I AND NIR-II DYES FOR FLUORESCENCE-GUIDED SURGERY OF NON-SMALL CELL LUNG CANCER
#263713
ScholarlyCommons at Penn
Risk factors and prognostic impact of venous thromboembolism in Asian patients with non-small cell lung cancer
#450643
S-Space: Seoul National University
Evaluation of the Efficacy and Safety of AL2846 Capsule Combined With TQB2450 Injection Compared to Docetaxel Injection in Advanced Non-small Cell Lung Cancer Patients Who Have Failed With Immunotherapy.
#471462
ClinicalTrials.gov
QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors
#474767
ClinicalTrials.gov
Standardization of a Platform of Preclinical Models Derived From NSCLC Patients
#407729
ClinicalTrials.gov
Chemo-immunotherapy Induction Followed by Hypo-radiotherapy in LA-NSCLC(CHIC)
#463716
ClinicalTrials.gov
Safety and Efficacy Study of Nab®-Paclitaxel With CC-486 or Nab®-Paclitaxel With Durvalumab, and Nab®-Paclitaxel Monotherapy as Second/Third-line Treatment for Advanced Non-small Cell Lung Cancer
#256863
ClinicalTrials.gov
Trial of Bi-shRNA-furin and GMCSF Augmented Autologous Tumor Cell Vaccine for Advanced Cancer
#148566
ClinicalTrials.gov
Mechanism of Action Trial of ColoAd1
#807673
ClinicalTrials.gov
Efficacy and Safety of Immunotherapy in Non-small Cell Lung Cancer With Uncommon Histological Type
#363599
ClinicalTrials.gov
Survival imProvement in Lung cancEr iNduced by DenOsUmab theRapy
#837679
ClinicalTrials.gov
Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors
#802745
ClinicalTrials.gov
Cardiac MRI Biomarker Testing (GCC 1618)
#827882
ClinicalTrials.gov
A Study of a Personalized Neoantigen Cancer Vaccine
#314340
ClinicalTrials.gov
SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation
#826598
ClinicalTrials.gov
Altered sphingolipid metabolism is associated with osimertinib resistance in non-small cell lung cancer
#201215
Spiral
ARGONAUT: Stool and Blood Sample Bank for Cancer Patients
#121332
ClinicalTrials.gov
Study of Nivolumab (BMS-936558) in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in Subjects With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC) (CheckMate 012)
#125851
ClinicalTrials.gov
Treatment Sequencing and Immunotherapy Rechallenge in Advanced Non-Small-Cell Lung Cancer: Final 24-Month Real-World Results from the French LIST Study
#178175
HAL (France)
A Prospective, Open-label, Single-center, Single-arm Phase II Clinical Study of Cadonilimab (AK104) Combined With Monotherapy Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer With Negative Driver Genes and Failed Immunotherapy
#279518
ClinicalTrials.gov
Pembrolizumab, Lenvatinib and Chemotherapy After TKIs in NSCLC
#332765
ClinicalTrials.gov
Efficacy of Argon-Helium Cryoablation Plus PD-1 Inhibitors in NSCLC
#813571
ClinicalTrials.gov
Immune Response to Immunotherapy in Lung Cancer: Study of Sputum and Blood Samples
#812848
ClinicalTrials.gov
IR-guided Ablation (IRGA) Combined With Stereotactic Ablative Radiation (SABR) for Large Lung Tumors
#813972
ClinicalTrials.gov
Surgery for Early Lung Cancer With Preoperative Erlotinib (Tarceva): A Clinical Phase II Trial (SELECT)
#830453
ClinicalTrials.gov
Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, Pembrolizumab, Nivolumab and Atezolizumab in Treating Patients With Advanced Melanoma, Lung, or Kidney Cancer
#238105
ClinicalTrials.gov
Targeting ODC as an Immunotherapeutic Target in STK11 (LKB1) Pathway-Deficient NSCLC (DFMO)
#451475
ClinicalTrials.gov
← Previous
Page 10 of 20
Next →
Topic record
· derived from the Conceptio knowledge graph (shared subject terms across the corpus)
Conceptio Open Knowledge Archive — topic hubs link to canonical document pages with full provenance.